Supply Chain Ecosystem Analysis now part of DBMR Reports
Market Size in USD Billion
| 2026 –2033 | |
|
|
USD 3.94 Billion |
| USD 11.23 Billion | |
| % | |
|
Global Oncology Day-Care Treatment Services Market, By Component (Software and Services), By Type( Traditional EMR, Speech Enabled EMR, Interoperable EMR, and Others) - Industry Trends and Forecast to 2033
The global Oncology Day-Care Treatment Services market was valued at USD 3.94 billion in 2025 and is projected to reach USD 11.23 billion by 2033, growing at a CAGR of 14.00% from 2026 to 2033. The market is experiencing consistent growth driven by rising global cancer prevalence, increasing demand for cost-effective outpatient oncology care, and expanding adoption of day-care treatment models that reduce hospital burden and improve patient convenience. The shift toward minimally invasive cancer therapies, combined with advancements in chemotherapy, immunotherapy, and targeted drug delivery systems, is accelerating the adoption of oncology day-care treatment services. Hospitals and specialized cancer centers are increasingly focusing on short-stay treatment protocols that allow patients to receive chemotherapy, infusion therapy, and supportive cancer care without overnight hospitalization.
The increasing pressure on healthcare systems due to rising patient volumes, along with growing preference for patient-centric and affordable treatment settings, is compelling healthcare providers and oncology centers to expand day-care facilities. In addition, supportive government initiatives for cancer care infrastructure development, rising healthcare expenditure, and improved access to oncology specialists in both developed and emerging markets are further strengthening the adoption of global oncology day-care treatment services.
Key Market Trends & Insights
Market Size & Forecast
Get Exclusive Sample Copy of this Report Here
|
Attributes
|
Oncology Day-Care Treatment Services Key Market Insights
|
|
Segments Covered
|
|
|
Countries Covered
|
North America
· U.S.
· Canada
· Mexico
Europe
· Germany
· France
· U.K.
· Netherlands
· Switzerland
· Belgium
· Russia
· Italy
· Spain
· Turkey
· Rest of Europe
Asia-Pacific
· China
· Japan
· India
· South Korea
· Singapore
· Malaysia
· Australia
· Thailand
· Indonesia
· Philippines
· Rest of Asia-Pacific
Middle East and Africa
· Saudi Arabia
· U.A.E.
· South Africa
· Egypt
· Israel
· Rest of Middle East and Africa
South America
· Brazil
· Argentina
· Rest of South America
|
|
Key Market Players
|
• Ipsen (France) • Bayer AG (Germany) • AstraZeneca plc (U.K.) • Roche Holding AG (Switzerland) • Pfizer Inc. (U.S.) • Novartis AG (Switzerland) • Merck & Co., Inc. (U.S.) • Bristol Myers Squibb (U.S.) • Eli Lilly and Company (U.S.) • Johnson & Johnson (U.S.) • Teva Pharmaceutical Industries Ltd. (Israel) • Amgen Inc. (U.S.) • Sanofi (France) • Thermo Fisher Scientific Inc. (U.S.) • HCA Healthcare (U.S.) • UnitedHealth Group (Optum) (U.S.) • Fortis Healthcare (India) • Apollo Hospitals Enterprise Ltd. (India) • Manipal Hospitals (India) • Spire Healthcare Group plc (U.K.) • IHH Healthcare Berhad (Malaysia) • NMC Health (UAE) • Icon Group (Australia) • Varian Medical Systems (Siemens Healthineers) (Germany) • GE HealthCare (U.S.) • Koninklijke Philips N.V. (Netherlands) • Becton, Dickinson and Company (BD) (U.S.) • ChemoTech (Sweden) • Accuray Incorporated (U.S.) • Elekta AB (Sweden) • Hologic, Inc. (U.S.) • Sun Pharmaceutical Industries Ltd. (India) • Lupin Limited (India) • Dr. Reddy’s Laboratories (India) • Zydus Lifesciences (India)
|
|
Market Opportunities
|
· Expansion of outpatient oncology day-care infrastructure
· Integration of precision oncology and targeted therapies
· Growth of home-to-hospital hybrid care models
|
|
Value Added Data Infosets
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.
|
Trend: Rising Adoption of Outpatient and Short-Stay Oncology Treatment Models
Healthcare systems worldwide are increasingly shifting toward outpatient oncology care, where patients receive chemotherapy, immunotherapy, and targeted infusions in day-care settings without prolonged hospitalization. This transition is driven by rising cancer incidence and the need to reduce inpatient burden on hospitals. For instance, in the U.S. and several European countries, more than 60% of chemotherapy sessions for solid tumors are now administered in outpatient oncology units, reflecting a strong shift toward ambulatory care models. Hospitals are also adopting fast-track treatment pathways for breast cancer, lung cancer, and colorectal cancer patients, improving patient throughput and reducing treatment costs while maintaining clinical outcomes.
Key Market Driver: Rising Global Cancer Burden and Expansion of Ambulatory Oncology Infrastructure
The increasing prevalence of cancer is a major driver of the oncology day-care treatment services market. According to global oncology estimates, cancer cases are projected to rise significantly over the next decade, with breast, lung, and colorectal cancers among the most commonly diagnosed. For example, breast cancer alone accounts for over 2 million new cases annually worldwide, creating sustained demand for infusion-based therapies that are increasingly delivered in outpatient settings. Hospitals and specialized cancer centers are expanding day-care oncology units equipped with infusion chairs, chemotherapy preparation systems, and real-time patient monitoring tools. In North America, large cancer networks such as MD Anderson Cancer Center and Mayo Clinic have significantly expanded outpatient infusion capacity to accommodate rising patient volumes, reducing inpatient load and improving care efficiency.
Key Restraint/Challenge: High Cost of Advanced Oncology Care Infrastructure and Skilled Workforce Shortage
A major challenge in the oncology day-care treatment services market is the high cost of establishing and maintaining advanced outpatient cancer care facilities. Setting up infusion centers requires significant investment in chemotherapy preparation rooms, biosafety systems, electronic medical record integration, and trained oncology nursing staff. In addition, the shortage of skilled oncology specialists and chemotherapy-trained nurses in emerging economies limits service expansion. Treatment complexity is further increased by the need for continuous patient monitoring and management of adverse drug reactions in real time, which requires advanced clinical infrastructure and increases operational costs for healthcare providers. For instance, according to healthcare workforce reports from multiple OECD countries, oncology nursing shortages have reached double-digit percentage gaps in some regions, particularly in rural and semi-urban healthcare facilities. In countries such as India and parts of Southeast Asia, limited availability of specialized cancer care infrastructure forces many patients to travel long distances to urban cancer centers, increasing treatment delays and overall healthcare burden. Similarly, smaller private hospitals often avoid establishing full-scale day-care oncology units due to high setup costs for infusion equipment, HEPA-filtered preparation rooms, and compliance with strict chemotherapy handling regulations, further restricting market penetration in cost-sensitive regions.
Key Market Opportunity: Expansion of Precision Oncology, Immunotherapy, and Digital Health Integration
The integration of precision oncology and immunotherapy-based treatment protocols presents a major growth opportunity for the market. Increasing use of biomarker-driven therapies is enabling more personalized treatment regimens, which are well-suited for controlled day-care settings. In addition, digital health technologies such as AI-based patient monitoring, remote symptom tracking, and cloud-connected oncology platforms are improving treatment continuity outside hospital settings. For example, several cancer centers in Europe and the U.S. are deploying AI-enabled infusion monitoring systems that track patient vitals in real time and predict adverse reactions during chemotherapy. Growing investments in oncology infrastructure across Asia-Pacific, particularly in India and China, are further accelerating adoption of modern outpatient cancer care models.
The Global Oncology Day-Care Treatment Services market is segmented on the basis of component, type, and geography.
By Component
On the basis of component, the global Oncology Day-Care Treatment Services market is segmented into software and services. The Software segment dominated the market with an estimated 58.4% share in 2025, owing to the increasing adoption of electronic medical records (EMR), clinical workflow management systems, and oncology-specific decision support platforms across hospitals and cancer care centers. Software solutions are widely preferred due to their ability to improve treatment accuracy, streamline patient data management, enhance appointment scheduling, and enable real-time clinical decision-making. The growing integration of AI-enabled analytics, cloud-based healthcare platforms, and interoperable hospital information systems is further strengthening the dominance of this segment. In addition, rising investments in digital healthcare infrastructure and government initiatives promoting healthcare digitization are accelerating software adoption across oncology day-care facilities globally.
The Services segment is expected to witness the fastest growth, registering a CAGR of 7.3% from 2026 to 2033, driven by the increasing need for system implementation, maintenance, training, consulting, and ongoing technical support in oncology care environments. Hospitals and cancer treatment centers are increasingly relying on managed services to ensure seamless operation of EMR systems and oncology workflows. The rising complexity of healthcare IT ecosystems, coupled with the demand for data security, regulatory compliance, and system interoperability, is further fueling service adoption. In addition, expansion of outsourced healthcare IT services, especially in emerging economies, is significantly contributing to segment growth.
By Type
On the basis of type, the global Oncology Day-Care Treatment Services market is segmented into traditional EMR, speech enabled EMR, interoperable EMR, and others. The Traditional EMR segment dominated the market with an estimated 39.6% share in 2025, due to its widespread adoption in hospitals and established healthcare systems that rely on basic digital record-keeping for oncology patients. Traditional EMR systems are widely used because of their lower implementation cost, ease of deployment, and familiarity among healthcare professionals. These systems support essential functions such as patient documentation, treatment tracking, and billing management, making them highly suitable for day-care oncology centers in both developed and developing regions. Continued reliance on legacy hospital IT infrastructure further supports the dominance of this segment.
The Interoperable EMR segment is expected to witness the fastest growth, registering a CAGR of 8.1% from 2026 to 2033, driven by increasing demand for seamless data exchange across healthcare systems, hospitals, laboratories, and diagnostic centers. Interoperable EMR systems enable real-time sharing of patient records, improving coordination in oncology treatment and enhancing clinical decision-making. Growing adoption of value-based care models, government mandates for healthcare interoperability, and expansion of integrated cancer care networks are accelerating segment growth. In addition, rising integration of AI, cloud computing, and advanced analytics into interoperable EMR platforms is further boosting their adoption in oncology day-care treatment services globally.
The North America Oncology Day-Care Treatment Services market is witnessing strong growth due to advanced healthcare infrastructure, high cancer screening rates, and increasing adoption of outpatient oncology treatment models across hospitals and specialized cancer centers. The region benefits from strong presence of leading oncology service providers, well-established infusion therapy networks, and widespread use of chemotherapy and immunotherapy in day-care settings. In addition, rising healthcare expenditure and strong reimbursement frameworks are supporting the shift toward cost-effective ambulatory cancer care delivery across the United States and Canada. Growing emphasis on early diagnosis, precision oncology, and patient-centric treatment pathways continues to accelerate market expansion across the region.
U.S. Oncology Day-Care Treatment Services Market Insight
The U.S. Oncology Day-Care Treatment Services market is witnessing strong growth due to advanced healthcare infrastructure, high adoption of outpatient oncology care models, and strong presence of leading cancer treatment centers across the country. Hospitals and specialized oncology clinics are increasingly shifting toward day-care chemotherapy, immunotherapy, and targeted infusion therapies to reduce inpatient burden and improve patient convenience. The country’s well-developed reimbursement systems and strong insurance coverage further support the adoption of ambulatory oncology services. In addition, increasing cancer prevalence, rising focus on early diagnosis, and growing use of precision oncology approaches are accelerating demand for structured day-care treatment services across major healthcare networks such as comprehensive cancer centers and large hospital systems.
Europe Oncology Day-Care Treatment Services Market Insight
The Europe Oncology Day-Care Treatment Services market remains a major contributor to global revenue, driven by strong public healthcare systems, increasing cancer burden, and widespread adoption of minimally invasive and outpatient oncology care models. The region has a high penetration of structured day-care oncology units across hospitals, supported by government-funded healthcare programs and strict clinical treatment guidelines. Countries such as Germany, France, and the U.K. are increasingly investing in modern infusion centers and digital oncology workflows to improve patient outcomes and reduce inpatient hospital pressure. Growing integration of precision medicine and standardized cancer care pathways is further strengthening Europe’s position in the global market.
U.K. Oncology Day-Care Treatment Services Market Insight
The U.K. Oncology Day-Care Treatment Services market is experiencing steady growth, supported by the National Health Service (NHS) focus on reducing hospital stays and expanding outpatient cancer treatment capacity. Increasing adoption of chemotherapy day units, home-to-hospital hybrid care models, and digital patient monitoring systems is improving treatment efficiency. In addition, rising cancer incidence and government initiatives for early diagnosis and faster treatment access are driving demand for advanced oncology day-care services across the country.
Germany Oncology Day-Care Treatment Services Market Insight
The Germany Oncology Day-Care Treatment Services market is expanding steadily due to strong healthcare infrastructure, high adoption of advanced oncology treatment protocols, and increasing focus on ambulatory cancer care delivery. German hospitals are increasingly shifting toward outpatient chemotherapy and immunotherapy services to improve efficiency and reduce inpatient burden. Continuous investment in oncology research, precision medicine, and structured cancer care pathways is further supporting market growth in the country.
Asia-Pacific Oncology Day-Care Treatment Services Market Insight
The Asia-Pacific Oncology Day-Care Treatment Services market is expected to witness rapid growth, driven by rising cancer prevalence, expanding healthcare infrastructure, and increasing healthcare expenditure across emerging economies. Countries such as China, India, and Japan are investing heavily in modern oncology care facilities and outpatient treatment centers to manage growing patient volumes. Increasing awareness about early cancer detection, improving access to healthcare services, and rising adoption of cost-effective day-care treatment models are further accelerating regional market expansion.
Japan Oncology Day-Care Treatment Services Market Insight
The Japan Oncology Day-Care Treatment Services market is witnessing consistent growth due to a rapidly aging population, high cancer incidence rates, and advanced healthcare delivery systems. Hospitals in Japan are increasingly adopting outpatient chemotherapy and precision oncology approaches to improve patient comfort and reduce hospital stay durations. Strong integration of digital health technologies and structured cancer care programs is further enhancing treatment efficiency in the country.
China Oncology Day-Care Treatment Services Market Insight
The China Oncology Day-Care Treatment Services market is growing rapidly, driven by expanding healthcare infrastructure, rising cancer burden, and strong government focus on improving oncology care accessibility. Increasing investments in urban hospital networks, specialized cancer centers, and outpatient infusion facilities are supporting market expansion. In addition, growing awareness of early cancer screening and rising adoption of standardized chemotherapy day-care protocols are positioning China as one of the fastest-growing markets globally.
The Oncology Day-Care Treatment Services industry is primarily led by well-established companies, including:
SKU-
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.